The Normalization of Brain 18F-fluorodeoxy-D-glucose Positron Emission Tomography Hypometabolism following Electroconvulsive Therapy in a 55-year-old Woman with Treatment-resistant Late Onset Depression: A Case Report
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Major depressive disorder, especially in later life, has heterogeneous clinical characteristics and treatment responses. Symptomatically, psychomotor retardation, lack of energy, and apathy tends to be more common in people with late-onset depression (LOD). Despite recent advances in psychopharmacologic treatments, 20% to 30% of patients with mood disorders experience inadequate responses to medication, often resulting in a trial of electroconvulsive therapy (ECT). However, the therapeutic mechanism of ECT is still unclear. By using 18F-fluorodeoxy-D-glucose positron emission tomography-computed tomography (18F-FDG PET/CT), we can obtain the status of brain metabolism in patients with neuropsychiatric disorders and changes during psychiatric treatment course. The object of this case report is evaluating the effect of ECT on brain metabolism in treatment-refractory LOD by PET/CT and understanding the mode of action of ECT. In this case report, we presented a 55-year-old female patient who suffered psychotic depression that was resistant to pharmacological treatment. Several antidepressants and atypical antipsychotics were applied but there was no improvement in her symptoms. The patient presented not only depressed mood and behaviors but also deficit in cognitive functions. We found decreased diffuse cerebral metabolism in her brain 18F-FDG PET/CT image. ECT resulted in amelioration of the patients’ symptoms and another brain PET imaging 7 weeks after the last ECT course showed that her brain metabolism was normalized.
Abstract
Major depressive disorder, especially in later life, has heterogeneous clinical characteristics and treatment responses. Symptomatically, psychomotor retardation, lack of energy, and apathy tends to be more common in people with late-onset depression (LOD). Despite recent advances in psychopharmacologic treatments, 20% to 30% of patients with mood disorders experience inadequate responses to medication, often resulting in a trial of electroconvulsive therapy (ECT). However, the therapeutic mechanism of ECT is still unclear. By using 18F-fluorodeoxy-D-glucose positron emission tomography-computed tomography (18F-FDG PET/CT), we can obtain the status of brain metabolism in patients with neuropsychiatric disorders and changes during psychiatric treatment course. The object of this case report is evaluating the effect of ECT on brain metabolism in treatment-refractory LOD by PET/CT and understanding the mode of action of ECT. In this case report, we presented a 55-year-old female patient who suffered psychotic depression that was resistant to pharmacological treatment. Several antidepressants and atypical antipsychotics were applied but there was no improvement in her symptoms. The patient presented not only depressed mood and behaviors but also deficit in cognitive functions. We found decreased diffuse cerebral metabolism in her brain 18F-FDG PET/CT image. ECT resulted in amelioration of the patients’ symptoms and another brain PET imaging 7 weeks after the last ECT course showed that her brain metabolism was normalized.
참고문헌 (21)
- Gallagher D, "Late life depression : a comparison of risk factors and symptoms according to age of onset in community dwelling older adults", Int J Geriatr Psychiatry, 25, pp.981~987 (2010)
- Janssen J, "Late-life depression : the differences between early-and late-onset illness in a community-based sample", Int J Geriatr Psychiatry, 21, pp.86~93 (2006)
- Korten NC, "Early and late onset depression in young and middle aged adults:differential symptomatology, characteristics and risk factors?", J Affect Disord, 138, pp.259~267 (2012)
- Grayson L, "A systematic review comparing clinical features in early age at onset and late age at onset late-life depression", J Affect Disord, 150, pp.161~170 (2013)
- Corruble E, "Association between age of onset and symptom profiles of late-life depression", Acta Psychiatr Scand, 118, pp.389~394 (2008)
- Thase ME, "Psychopharmacology: the fourth generation of progress" (1995), Rave Press
- Janicak PG, "Efficacy of ECT : a meta-analysis", Am J Psychiatry, 142, pp.297~302 (1985)
- Getz GE, "The effect of electroconvulsive therapy on executive functioning in a treatmentresistant man with depression: a case report", J ECT, 30, pp.e11~e12 (2014)
- Marano CM, "The relationship between fasting serum glucose and cerebral glucose metabolism in late-life depression and normal aging", Psychiatry Res, 222, pp.84~90 (2014)
- Oda K, "Regional cerebral blood flow in depressed patients with white matter magnetic resonance hyperintensity", Biol Psychiatry, 53, pp.150~156 (2003)
- Schmidt EZ, "Changes in brain metabolism after ECT-positron emission tomography in the assessment of changes in glucose metabolism subsequent to electroconvulsive therapy--lessons, limitations and future applications", J Affect Disord, 106, pp.203~208 (2008)
- Drevets WC, "Subgenual prefrontal cortex abnormalities in mood disorders", Nature, 386, pp.824~827 (1997)
- Bell KA, "Decreased glucose metabolism in the dorsomedial prefrontal cortex in depression", Biol Psychiatry, 45(8 Suppl 1), pp.118S~ (1999)
- Henry ME, "The effects of ECT on brain glucose : a pilot FDG PET study", J ECT, 17, pp.33~40 (2001)
- McCormick LM, "Metabolic correlates of antidepressant and antipsychotic response in patients with psychotic depression undergoing electroconvulsive therapy", J ECT, 23, pp.265~273 (2007)
- Enev M, "Imaging onset and propagation of ECTinduced seizures", Epilepsia, 48, pp.238~244 (2007)
- Nobler MS, "Decreased regional brain metabolism after ECT", Am J Psychiatry, 158, pp.305~308 (2001)
- Suwa T, "Corticolimbic balance shift of regional glucose metabolism in depressed patients treated with ECT", J Affect Disord, 136, pp.1039~1046 (2012)
- Awata S, "Changes in regional cerebral blood flow abnormalities in late-life depression following response to electroconvulsive therapy", Psychiatry Clin Neurosci, 56, pp.31~40 (2002)
- Drevets WC, "Functional anatomical correlates of antidepressant drug treatment assessed using PET measures of regional glucose metabolism", Eur Neuropsychopharmacol, 12, pp.527~544 (2002)
- Guze BH, "Electroconvulsive therapy and brain glucose metabolism", Convuls Ther, 7, pp.15~19 (1991)